Multidisciplinary effort boosts the George Washington University COVID-19 vaccine clinical trial. And when it comes to enrollment successes, Magnus points to GW's storied history in forming bonds with the local community. "The context of the HIV Prevention Network is so important and the relationships that helped us build," she says. "There’s nothing we can do by ourselves, it's really hand-in-hand with the community. We're fortunate that for decades we’ve had these connections. We trust them and they trust us, it’s open and transparent." Continue reading this article to see the process of setting up the site, the power of volunteers, and many more aspects of starting the COVID-19 Vaccine Clinical Trial.
A Game Winning Shot
Latest News
Uganda has detected what appears to be a localized outbreak of Marburg virus disease, with two cases identified in a single family, according to a source familiar with the situation, although the Ugandan government had not yet publicly confirmed the outbreak at the time of publication. The…
The GW VRU is a site for a clinical trial to examine Pfizer's new C. diff vaccine.
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.